9 Nov 2010: NorDiag's partner in Olerup International AB (HLA Typing segment), LinkMed, has today reported its Q3 results at the Stockholm Stock Exchange. NorDiag owns Olerup International together with LinkMed and SSP Primers.

LinkMed's Q3-report is attached. NorDiag will report Q3 results at November 18.

Contact: CFO Tone Kvaale + 47 915 19576

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and tests) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 38,4 man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.

For further information - www.nordiag.com.

Find the attached Q3 report here

Read the notice in Norwegian here